Dr. Ruba Benini, Dr. Husam Kayyali and Dr. Ahmed Al Hammadi
Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, will host its 6th Paediatric Neuroscience Conference (PNC 2026) from October 29 to 31, 2026. PNC 2026 will be held in conjunction with the 3rd GCC paediatric Neurology Conference.
The three-day programme will cover the diagnosis and treatment of paediatric neurological and neurosurgical conditions including common disorders as well as complex and rare diseases.
Div. Chief of Paediatric Neurology at Sidra Medicine and Chair of PNC 2026, Dr. Husam Kayyali said: “Paediatric neuroscience is changing rapidly. Advances in genomics, precision medicine, gene therapy and artificial intelligence are creating new opportunities to diagnose and treat complex conditions. At Sidra Medicine, we are committed to advancing these areas through clinical care, research and education. PNC 2026 will help strengthen knowledge exchange and support the future of paediatric neuroscience in Qatar and the region.”
Key topics at the conference will include gene therapies, clinical trials for rare neurological disorders and the use of artificial intelligence in neurology and neurosurgery. Experts will also share new research and clinical approaches in paediatric neuroscience.
Head of the Scientific Planning Committee for PNC 2026, Dr. Ruba Benini said: “PNC 2026 provides an important platform for specialists to exchange knowledge and explore the latest advances in paediatric neuroscience. Our scientific programme has been carefully developed to address key areas in the field, bringing together expert speakers and relevant topics that support learning, collaboration and continued professional development.”
Chair of Paediatric Medicine at Sidra Medicine Dr. Ahmed Al Hammadi said: “This year’s conference is unique as it brings together our flagship Paediatric Neuroscience Conference and the 3rd GCC Paediatric Neurology Conferences together. Our joint efforts will create a platform to share knowledge, research and clinical practices in paediatric neuroscience, neurology and neurosurgery. By strengthening collaboration across Qatar, the region and internationally, we can continue to improve care for children and their families.”
PNC 2026 will be held in a hybrid format, with in-person sessions in Doha and virtual access for participants worldwide. The conference has been accredited for 16.25 Continuing Professional Development (CPD) hours. The conference is open to physicians, nurses, allied health professionals, pharmacists, residents, students and researchers working in paediatric neuroscience.
